Literature DB >> 7740652

Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.

M A Noordzij1, G J van Steenbrugge, T H van der Kwast, F H Schröder.   

Abstract

Neuroendocrine cells can be demonstrated in normal, hyperplastic and neoplastic prostatic tissues. The products secreted by these cells can be used as tissue and/or serum markers but may also have biological effects. Neuroendocrine cells in prostate cancer most probably do not contain the androgen receptor and are therefore primarily androgen independent. Some of the neuropeptides secreted by the neuroendocrine cells may act as growth factor by activation of membrane receptors in an autocrine-paracrine fashion or by ligand-independent activation of the androgen receptor in neighboring non-neuroendocrine cells. Evidence is accumulating from experiments with tumor models that neuropeptides indeed can influence the growth of prostatic tumor cells. Future research on neuroendocrine differentiation may answer some questions concerning the biological behavior of clinical prostatic tumors.

Entities:  

Mesh:

Year:  1995        PMID: 7740652     DOI: 10.1007/BF00296871

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  110 in total

1.  Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium.

Authors:  S C Kirkland
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

2.  Calcitonin, katacalcin, and calcitonin gene-related peptide in the human prostate. An immunocytochemical and immunoelectron microscopic study.

Authors:  P A di Sant'Agnese; K L de Mesy Jensen; R K Ackroyd
Journal:  Arch Pathol Lab Med       Date:  1989-07       Impact factor: 5.534

3.  Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium.

Authors:  J G Azzopardi; D J Evans
Journal:  J Pathol       Date:  1971-08       Impact factor: 7.996

4.  Prostatic carcinoma: histological and immunohistological factors affecting prognosis.

Authors:  R J Cohen; G Glezerson; Z Haffejee; D Afrika
Journal:  Br J Urol       Date:  1990-10

5.  Diffuse carcinoid of prostate.

Authors:  P W Wasserstein; R L Goldman
Journal:  Urology       Date:  1981-10       Impact factor: 2.649

6.  Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.

Authors:  C Hagn; K W Schmid; R Fischer-Colbrie; H Winkler
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

7.  Do neuroendocrine cells in human prostate cancer express androgen receptor?

Authors:  J L Krijnen; P J Janssen; J A Ruizeveld de Winter; H van Krimpen; F H Schröder; T H van der Kwast
Journal:  Histochemistry       Date:  1993-11

8.  Isolation of a human seminal plasma peptide with bombesin-like activity.

Authors:  L Gnessi; S Ulisse; A Fabbri; E A Jannini; V Bonifacio; C Moretti; G Spera; A Isidori
Journal:  Fertil Steril       Date:  1989-06       Impact factor: 7.329

9.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells.

Authors:  J C Willey; J F Lechner; C C Harris
Journal:  Exp Cell Res       Date:  1984-07       Impact factor: 3.905

10.  Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

Authors:  A V Schally; T W Redding
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

View more
  12 in total

1.  Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver.

Authors:  M Ogasawara; J Murata; Y Kamitani; K Hayashi; I Saiki
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

Review 2.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

3.  Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.

Authors:  J Jongsma; M H Oomen; M A Noordzij; W M Van Weerden; G J Martens; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

4.  Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer.

Authors:  Constantinos Constantinides; Andreas C Lazaris; Konstantinos N Haritopoulos; Dimitrios Pantazopoulos; Michalis Chrisofos; Aris Giannopoulos
Journal:  World J Urol       Date:  2003-07-05       Impact factor: 4.226

5.  The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Authors:  Ren Jie Jin; Yongsoo Lho; Linda Connelly; Yongqing Wang; Xiuping Yu; Leshana Saint Jean; Thomas C Case; Katharine Ellwood-Yen; Charles L Sawyers; Neil A Bhowmick; Timothy S Blackwell; Fiona E Yull; Robert J Matusik
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

6.  Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder.

Authors:  József Jászai; Christine A Fargeas; Michael Haase; Lilla M Farkas; Wieland B Huttner; Denis Corbeil
Journal:  Histochem Cell Biol       Date:  2008-06-07       Impact factor: 4.304

7.  Neuroendocrine differentiation in human prostatic tumor models.

Authors:  M A Noordzij; W M van Weerden; C M de Ridder; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Effects of combined androgen blockade on bone metabolism and density in men with locally advanced prostate cancer.

Authors:  M Ozgür Tan; Cenk Yilmaz; M Cemil Uygur; Burcu Duyur; Demokan Erol
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 9.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

10.  Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions.

Authors:  Moumita Chatterjee; Linda Sequeira; Mashariki Jenkins-Kabaila; Cara W Dubyk; Surabhi Pathak; Kenneth L van Golen
Journal:  J Signal Transduct       Date:  2011-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.